44
total announcements
KIMS.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 15 Oct 2026
Market Cap
₹29,104 Cr
P/E (TTM)
135.9
P/E (Forward)
40.9
EPS (TTM)
₹5.10
52W Low
₹575.80
52W High
₹858.00
Dividend Yield
0.00%
Beta
0.27
Price / Book
12.3
Debt / Equity
166.2
Revenue (TTM)
₹4,213 Cr
Gross Margin
59.32%
Operating Margin
10.39%
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26, along with a Reasonable Assurance Report, as required by SEBI's listing regulations.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has submitted its Integrated Annual Report for the FY 2025-26, as per Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 27, 2026
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has informed the Exchange about the availability of the audio recording of the Company's Conference Call dated August 7, 2025 with Investors/ Analysts for Q1 FY27 on the Company's website.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has informed the Exchange about the schedule of an Analyst/Institutional Investor Meeting on August 12, 2026, at Emkay Confluence 2026 Mumbai, India.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has informed the Exchange about the compliance with Regulation 47 of the SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, regarding the unaudited (Standalone and Consolidated) financial results for the 01st quarter ended 30th June 2026.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has issued a Monitoring Agency Report for the quarter ended June 30, 2026, as per SEBI Regulations and Monitoring Agency Agreement dated June 16, 2026. The report pertains to the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32, confirming NIL deviation or variation in the utilisation of proceeds of funds raised through Qualified Institutional Placement from the objects stated in the Placement Document dated 19th June, 2026.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has announced its unaudited financial results for the first quarter ended June 30, 2026, showing a growth of 36.1% in total revenue and 20.1% in EBITDA. The company's consolidated EPS for the period ended June 30, 2026, was INR 1.04, a degrowth of 47.2% on a year-on-year basis. The company has also highlighted its clinical achievements, including a rare milestone of completing 10,000 brain tumour surgeries successfully and a successful treatment of a patient with Weber-Christian disease without liver transplant.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has informed the Exchange about Investor Presentation, enclosing unaudited financial results for the 1st quarter ended June 30, 2026.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has submitted its unaudited standalone financial results for the quarter ended June 30, 2026. The Board of Directors has approved the financial results, which include a loan of up to ₹650 Crores to be advanced to any subsidiaries or associates, and a loan of up to ₹25 Crore to KIMS Hospital Enterprises Private Limited. The financial results are available on the company's website and on the websites of BSE Ltd and National Stock Exchange of India Ltd.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has informed the Exchange about a conference call with analysts and investors to discuss the company’s business strategy and outlook post the declaration of Q1FY27 financial results.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June, 2026.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on July 09, 2026, and informed the Exchange regarding voting results.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited held an Extra-Ordinary General Meeting on July 9, 2026, through video conferencing, to discuss and transact business items as per the notice and corrigendum issued on June 15 and July 4, 2026, respectively. The meeting was conducted in compliance with applicable provisions of the Companies Act, 2013, and the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has informed the Exchange about a newspaper advertisement published on 5 July 2026, informing the Members about the dispatch of the corrigendum to the Notice convening the Extraordinary General Meeting scheduled to be held on 9 July 2026.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has issued a corrigendum to the notice of its extraordinary general meeting, which includes clarifications and corrections to the proposed preferential issue of equity shares and the explanatory statement annexed to Item No. 1 of the EGM notice.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has issued a corrigendum to the notice of its extraordinary general meeting, which includes clarifications and rectification of typographical errors in the explanatory statement.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of unaudited financial results for the 1st quarter ending 30th June 2026.
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited has received approval from both BSE and NSE for the listing of 1,98,67,549 equity shares. These shares, with a face value of Rs. 2/- each, were issued to qualified institutional buyers through a Qualified Institutional Placement (QIP). This intimation confirms the successful completion of the regulatory process for the QIP shares to be traded on the exchanges.